/PRNewswire/ Amgen (NASDAQ:AMGN) and AstraZeneca today announced detailed results for tezepelumab, a potential first-in-class treatment, from the pivotal.
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and AstraZeneca Thursday said results from the Phase 3 study of tezepelumab in severe asthma patients, dubbed Navigator, have been published in the New England
Featured in How Abbas Zahedi Turned an Exhibition into a Mutual Aid Group
In collaboration with a team of neurologists, Abbas Zahedi transformed a cancelled exhibition into a therapeutic space for frontline workers
It is rare for the fallout of a show to become the show itself. But this is exactly what happened for London-based artist Abbas Zahedi. His latest solo exhibition, ‘Ouranophobia SW3’, opened last November in the old Chelsea Sorting Office, a semi-derelict warehouse across the road from Royal Brompton Hospital in west London. For reasons unrelated to COVID-19, the exhibition was abandoned by its organizers in the run up to the opening. This motivated Zahedi to rebirth the show, forming a new alliance – Sonic Support Group – that made the piece accessible exclusively to individuals working on the pandemic frontline.
AI methods predict COVID-19 patient outcomes using routine clinical data from ICUs
The investigators used machine learning to predict which patients might get worse and not respond positively to being turned onto their front in intensive care units (ICUs) - a technique known as proning that is commonly used in this setting to improve oxygenation of the lungs.
While the AI model was used on a retrospective cohort of patient data collected during the pandemic s first wave, the study demonstrates the ability of AI methods to predict patient outcomes using routine clinical information used by ICU medics.
The researchers say the approach, where each patient s data were analyzed day-by-day instead of only on admission, could be used to improve guidelines in clinical practice going forward. It could be applied to potential future waves of the pandemic and other diseases treated in similar clinical settings.